Destiny King, APRN
Family · Hot Springs, ARNPI 1104645837
Payments from drug & device makers
Across 40 payments — averaging $35.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$828
- AbbVie$102
- Sumitomo Pharma America, Inc.$83
- Coloplast$68
- Merck$47
- Endo USA, Inc.$39
- plus $234 from 10 others
What the payments were for
- Travel & lodging$74353%
- Food & beverage$66047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $828 |
| AbbVie | 6 | $102 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Coloplast | 4 | $68 |
| Merck | 2 | $47 |
| Endo USA, Inc. | 1 | $39 |
| Teleflex LLC | 2 | $36 |
| Pfizer | 2 | $34 |
| 180 Medical, Inc. | 1 | $28 |
| Procept Biorobotics Corporation | 1 | $25 |
| Antares Pharma, Inc. | 1 | $22 |
| Urogen Pharma, Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Photocure Inc | 1 | $16 |
| Angiodynamics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$578
How this compares
$1,402 in reported general payments places this provider in the 75th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $180 |
Paid to pharmacies, not to this prescriber.
Other family in Hot Springs
- Kayla StanageHot Springs$10K
- Robert McDanielsHot Springs$9K
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.